Pharmtechnology, LLC
- Country
- 🇧🇾Belarus
- Ownership
- Private
- Established
- 1991-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://ft.by/en/okomp-2
Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- Drug: Prestarium® A tablet
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 50
- Registration Number
- NCT06213610
- Locations
- 🇷🇺
Ligand Research LLC, Moscow, Russian Federation
Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- Drug: Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet
- First Posted Date
- 2023-07-11
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 50
- Registration Number
- NCT05940909
- Locations
- 🇷🇺
Ligand Research LLC, Moscow, Russian Federation
Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 60
- Registration Number
- NCT05934799
- Locations
- 🇷🇺
State Autonomous Healthcare Facility of the Yaroslavl Region "Clinical Hospital No. 2", Yaroslavl, Yaroslavl Region, Russian Federation
Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- Drug: Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 50
- Registration Number
- NCT05685277
- Locations
- 🇷🇺
Separate medical division "Comed" (Ligand Research LLC), Moscow, Russian Federation
Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- Drug: Liprimar® film-coated tablet 40 mg
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 50
- Registration Number
- NCT05642845
- Locations
- 🇷🇺
State Budgetary Healthcare Institution of the Yaroslavl Region "Clinical Hospital No. 2", Yaroslavl, Russian Federation
Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 50
- Registration Number
- NCT05438316
- Locations
- 🇷🇺
Ligand Research LLC, Moscow, Russian Federation
Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- Drug: Airtal® film-coated tablet 100 mg
- First Posted Date
- 2022-04-21
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 36
- Registration Number
- NCT05339373
- Locations
- 🇷🇺
X7 Clinical Research, Saint Petersburg, Russian Federation
Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2022-07-07
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 38
- Registration Number
- NCT05061901
- Locations
- 🇷🇺
Private healthcare institution "Clinical Hospital "RZD-Medicine" of the city of Yaroslavl", Yaroslavl, Yaroslavl Region, Russian Federation
Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- Drug: Toradiur® tablet 10 mg
- First Posted Date
- 2021-06-10
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 26
- Registration Number
- NCT04921566
- Locations
- 🇷🇺
Private healthcare institution "Clinical Hospital "RZD-Medicine" of the city of Yaroslavl", Yaroslavl, Yaroslavl Region, Russian Federation
Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Pharmtechnology LLC
- Target Recruit Count
- 44
- Registration Number
- NCT04882826
- Locations
- 🇷🇺
Private healthcare institution "Clinical Hospital "RZD-Medicine" of the city of Yaroslavl", Yaroslavl, Russian Federation